NuePrism
NuePrism
Execution Verdict System
Uses simulated data No sign-up required Book a Live Demo

NuePrism Interactive Evaluation

Experience how NuePrism diagnoses execution problems
using simulated delivery data.

Today's Scenario
You are the Product Manager responsible for Product Saturn and Product Venus.
Release
Q2 2026
Status
Mid Sprint
Product Health
Critical

Traditional delivery dashboards show separate team boards with no shared view of product risk.

NuePrism has detected a cross-team execution breakdown threatening this release.

Your Objective

During this evaluation you will discover:

Which product commitment is actually at risk
Which teams and features are causing it
What coordinated action is required, and who owns it
What the product will deliver, and how that changes with intervention
What You'll Explore
1 Summary
2 Overview
3 Execution
4 Actions
5 Outcomes
Estimated Time
6–8
minutes
Uses simulated delivery data.
This demo does not connect to your systems or access real data.
This is not a guided tour. Explore freely. We recommend starting with the Primary Verdict on the Overview screen. Send Feedback
My Workspace Last updated at 15:00pm today
Interactive Product Tour Using simulated delivery data
Book Live Demo
My Actions
Viewing: Product Saturn • 5 Teams • Q2 2026
6
Open Actions
3
High-Priority Actions
4
Actions Due < 48hrs
4
Teams at Risk (Critical/Watch)
Top 3 Actions Requiring Attention View All Actions →
High
Protect Ledger Reconciliation and Payout Reliability; defer non-critical scope additions.
Entity: Product Saturn  •  Focus Area Cross-Team Dependency Risk
Due Today
May 6, 2026
View Details →
High
Escalate the stale, release-blocking PR blocking Payout Reliability.
Entity: Product Saturn  •  Focus Area Cross-Team Dependency Risk
Due Today
May 6, 2026
View Details →
High
Escalate Beta's unmerged currency-rounding and duplicate-settlement-row fixes blocking Ledger Reconciliation.
Entity: Product Saturn  •  Focus Area Feature Delivery Risk
Due Today
May 6, 2026
View Details →
My Teams
View All Entities
Focus Areas (across last 4 sprints)
My Products / Product DiagnosisLast diagnosis: 17 May 2026, 09:40

Product Saturn

Q2 '26 (Apr 1 – Jun 30)⌄26.2.4 (Day 5 of 10)⌄◧ Jira all teams · GitHub for 1 of 2
Teams Contributing to My Products
Compare team health at a glance, then open a team's own diagnosis for full team-level detail. This is a comparison view, not the product diagnosis — see Overview for that.
Team Health Features Owned Completion Confidence Features At Risk Scope Deviation (SP) Data Hygiene Evidence
Product Saturn
5 teams
At Risk 25
64%
5 features 84% Mixed Diagnosis ›
Team Alpha
Jira-only evidence
Critical 5
70%
2 features +14 SP (20%) 80% Jira Diagnosis ›
Team Beta
Jira + GitHub evidence
Critical 5
64%
2 features +3 SP (5%) 76% Jira + GitHub Diagnosis ›
Team Gamma
Jira-only evidence
Watch 5
81%
0 features +4 SP (8%) 88% Jira Diagnosis ›
Team Delta
Jira + GitHub evidence
Healthy 5
92%
0 features +1 SP (2%) 95% Jira + GitHub Diagnosis ›
Team Epsilon
Jira-only evidence
Watch 5
76%
1 feature +9 SP (20%) 79% Jira Diagnosis ›
Product Venus
3 teams
Critical 12
55%
3 features 61% Jira-only Diagnosis ›
◧ Mixed Evidence — Teams Beta and Delta additionally report on GitHub PR and CI signals; product verdicts on the Overview/Execution tabs account for this.

"Features Owned" reflects sole ownership — every feature has exactly one owning team; other teams may "touch" it as a dependency contributor (visible on the Execution tab) without co-owning it. Product Saturn has 25 committed features total this quarter, and Product Health/KPIs/Outcomes on the other tabs cover all 25. Gamma, Delta, and Epsilon don't have a full embedded team diagnosis in this demo (their "Open Diagnosis" is disabled above), but their features and health are reflected everywhere else.

Add Action
Please enter an action title and a due date.
Trouble viewing? Watch on YouTube
Executive Delivery Report — Preview
%%VENUS_ESC_SCRIPT%%